CannaSoul Analytics

About:

CannaSoul provides safe and reliable Cannabis-based products, treatments, and pharmaceuticals.

Top Investors: Synaptogenix

Description:

CannaSoul provides safe and reliable Cannabis-based products, treatments, and pharmaceuticals. Cannasoul is the first company in the world to analyze over 100 cannabinoids and 100 terpenes. In addition to the comprehensive phytocannabinoid and terpene analysis. It offers a unique and comprehensive endocannabinoid analysis in a wide range of matrixes. Cannasoul was founded by Shmuel Mandel in 2018.

Total Funding Amount:

$4M

Headquarters Location:

Caesarea, Hefa, Israel

Founded Date:

2018-03-01

Contact Email:

info(AT)cannasoul.co.il

Founders:

Shmuel Mandel

Number of Employees:

11-50

Last Funding Date:

2023-11-02

IPO Status:

Private

Industries: